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Introduction. Individuals with inflammatory bowel disease (IBD) have an increased risk of osteoporosis compared to the general
population. We aimed to improve the osteoporosis screening rate in the IBD patient population of the gastroenterology (GI)
fellows’ continuity clinics.Methods. Baseline preintervention data were collected on patients seen from July through September of
2018. Four simplified criteria for osteoporosis screening were extrapolated from 3 national guidelines. Among patients who met
any of these criteria, we determined the baseline screening rate. Fellows were then educated with a didactic session and handout
material, and a standardized template was incorporated into clinic notes. Following this intervention, screening rates were
reassessed from December 2018 through February 2019. Results. During the preintervention phase, fellows saw 80 patients with
IBD. Dual-energy X-ray absorptiometry (DEXA) scan was obtained in 44% of IBD patients who qualify for screening at the county
hospital clinic compared to 21% of veterans’ clinic IBD patients. In the postintervention period, screening rates remarkably
improved to 100% in the county hospital clinic and to 75% in the veterans’ clinic. Overall, the screening rate increased by 56%
(P< 0.001). Conclusions. A large percentage of IBD patients at risk for osteoporosis did not have appropriate bone mass density
testing. Educating GI fellows and adding a template to clinic notes were effective in significantly improving the number of patients
at risk of osteoporosis to receive appropriate screening test, a DEXA scan. Similar educational interventions should be considered
for providers caring for IBD patients to prevent complications of osteoporosis in these patients.
1. Introduction
Inflammatory bowel disease (IBD) is frequently encountered
in the practice of gastroenterologists. 'e incidence can vary
depending on the population studied. For example, the
annual incidence rates for Crohn’s disease (CD) and ul-
cerative colitis (UC) in a Veterans Affairs (VA) population
were 33 per 100,000 and 50 per 100,000 VA users, re-
spectively [1]. 'e incidence in the general population of
North America is reported to be up to 20.2 per 100,000
person-years for CD and 19.2 per 100,000 person-years for
UC [2]. Patients with limited health literacy are more likely
to have symptoms of active Crohn’s, depressive symptoms
and worse overall health [3]. In general, patients of the VA
and county hospitals tend to have lower educational and
socioeconomic status compared to the general population,
and they could also have worse IBD-related outcomes [4].
Individuals with IBD have an increased risk of osteo-
porosis compared to the general population. 'e prevalence
of osteoporosis in IBD patients is high, ranging from 13% to
42% [5–7]. 'e pathophysiology of decreased bone mineral
density (BMD) in this patient population is not completely
understood but thought to be multifactorial related to a state
of chronic inflammation, corticosteroid use, nutritional
deficiencies, and small bowel resections [8, 9].
Making a diagnosis of osteoporosis is important because
it is a known risk factor for bone fractures, and patients with
osteoporosis should receive appropriate treatment [10]. 'e
presence of osteoporosis and osteopenia can be determined
by measuring BMD, and this is commonly done using a
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DEXA scan. To exemplify the utility of BMD, if the BMD is
one standard deviation lower than age adjusted mean, the
relative risk of having a fracture increases by 1.6 to 2.6 [11].
Major gastroenterology societies, including the American
Gastroenterology Association (AGA), the American College
of Gastroenterology (ACG), and the European Crohn’s and
Colitis Organization (ECCO), have all recommended
screening UC and CD patients for osteopenia/osteoporosis,
although with small variations in defining the at-risk pa-
tients [5, 12, 13]. Given that the gastroenterologist is often
regarded as the main provider for IBD patients, gastroen-
terologists and primary care physicians are equally re-
sponsible to recommend preventive measures and screening
for osteoporosis, in addition to other healthcare mainte-
nance issues [12]. However, studies are concerning for low
osteoporosis screening rates and low adherence to the
abovementioned guidelines [6, 11, 14, 15].
In this study, we aimed to measure the overall osteo-
porosis screening rate in the IBD patient population of the
GI fellows’ continuity clinics at our institution and imple-
ment measures to improve it.
2. Methods
'is quality improvement study was developed and executed
by the trainees in our Gastroenterology and Hepatology
Fellowship Program within the context of our trainee
continuity clinics at the affiliated county hospital and VA
medical center. All trainees who participated in the initiative
were gastroenterology fellows. As the project was designed
as a quality improvement initiative, this study was exempt
from the Institutional Review Board (IRB) review.'is study
was conducted in compliance with the ethical standards of
our institution.
2.1. Inclusion/Exclusion Criteria. Baseline preintervention
data were collected on patients seen over a 12-week period.
We utilized the scheduling timesheets to determine the
patients seen by the fellows in their continuity clinics at the
two locations (VA clinic and county hospital clinic). We
included all adult patients who had a confirmed diagnosis of
IBD, as documented in GI clinic notes. 'e diagnosis of IBD
is typically made based on well-known clinical, endoscopic,
and histologic criteria.'e electronic chart was reviewed and
the following information was collected: age, sex, subtype of
IBD (UC, CD, or indeterminate colitis), whether they met
osteoporosis screening criteria, and whether a DEXA scan
had been obtained in the prior 2 years (by any of the patient’s
providers). Patients who were less than 18 years of age and
those who did not carry a diagnosis of IBD were excluded.
2.2. Determining Who Needs Osteoporosis Screening. To
determine if a patient should have a DEXA scan, we referred
to national osteoporosis screening guidelines. Because there
are many risk factors and conditions that predispose to
osteoporosis, we focused for the purposes of this study on
the essential factors that apply for the majority of patients.
We refer to those risk factors as the “simplified osteoporosis
screening criteria.” 'ose simplified criteria were extrapo-
lated from three guidelines (American College of Gastro-
enterology (ACG) 2017, United States Preventive Services
Task Force (USPSTF) 2018, and National Osteoporosis
Foundation (NOF) 2014). 'ey include females aged 65
years or older, males aged 70 years or older, use of oral
corticosteroid therapy in a dose ≥7.5mg/day of prednisone
equivalent for 3 or more consecutive months, and a previous
bone fracture in adult life occurring spontaneously or from a
trauma which normally would not result in a fracture in
healthy individuals. 'e presence of any of these screening
criteria was determined by retrospectively reviewing clinic
notes, medical problem lists, radiology studies, and medi-
cations dispensed by pharmacy.
2.3. Quality Initiative Intervention. Among patients who
met any of these criteria, we determined the baseline/pre-
intervention osteoporosis screening rate, defined as the
proportion of patients who had a bone DEXA scan in the
past 2 years. Fellows were then educated by means of a
didactic session along with handout material (Appendix A),
and a standardized template was incorporated into their
clinic notes (Appendix B). Following this educational in-
tervention, screening rates were reassessed over another 12-
week period by charts review. 'e postintervention
screening rate was defined as the proportion of subjects who
had DEXA scans performed within the past 2 years or or-
dered in clinic during the 12 weeks after the intervention.
Each fellow reviewed another fellow’s patients’ encounters in
both the preintervention and postintervention periods to
ensure an unbiased data collection. 'e pre- and post-
intervention screening rates were compared, and P values
were calculated using a two proportion Z-test in indepen-
dent groups.
3. Results
3.1. Preintervention Baseline Characteristics. During the
preintervention phase, fellows saw 743 patients, 80 of whom
had IBD (36 had UC, 42 had CD, and 2 with indeterminate
colitis). Of these 80 IBD patients, 45 were seen at the VA
clinic and 35 were seen in the county clinic. Ninety-three
percent at the VA clinic were male IBD patients compared to
37% at the county clinic. 'e VA patients were older than at
the county clinic (mean age of 61.6 years versus 46.8).
3.2. Preintervention Screening Rates. A total of 45 IBD pa-
tients (56%) met at least one of the determined osteoporosis
screening criteria, and 29 of those 45were seen at the VA clinic.
DEXA scan was obtained in 44% of IBD patients who qualify
for screening at the county hospital clinic, compared to only
21% of veterans’ clinic IBD patients. 'e most common in-
dications for screening were age criteria and steroid use.
3.3. Postintervention Baseline Characteristics. In the post-
intervention period, 81 patients with IBD were seen (36 had
UC, 42 had CD, and 3 with indeterminate colitis). More IBD
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patients were seen at the VA clinic (46 patients) compared to
the county clinic (35 patients). 'e demographics were
similar to those of the preintervention phase. Specifically, the
majority (98%) of the VA clinic patients were male as
compared to the majority being female (63%) at the county
clinic. In addition, the VA patients were older than at the
county clinic (mean age of 62.7 years versus 45.1).
3.4. Postintervention Screening Rates. Forty-seven IBD pa-
tients (58%) met at least one of the determined osteoporosis
screening criteria. Screening rates remarkably improved to
100% in the county hospital clinic (relative risk (RR)� 2.28,
P< 0.001) and to 75% in the veterans’ clinic (RR� 3.62,
P< 0.001). Overall, the combined screening rate in both
clinics increased from 29% to 85% (RR� 2.91, P< 0.001)
(Table 1).
4. Discussion
Our study showed that a large proportion of IBD patients
seen by GI fellows met one or more criteria for osteoporosis
screening, consistent with other studies in the literature that
also report high proportion among IBD patients [6].
However, before implementation of the educational
intervention, the majority of patients did not receive an
appropriate DEXA scan, indicating low compliance rate
with existing ACG and other guidelines. Previous studies
have also been published on low osteoporosis screening rates
in this patient population. In a nationwide study on IBD
patients in the Veterans Health Administration, only 15%
received a DEXA scan [14]. Similarly, in a large Swiss cohort,
osteoporosis screening rate varied among six medical cen-
ters, from 11% to 62% [11]. We theorize that the low
compliance rate in our group is most likely from not having
sufficient time to address all health maintenance issues
during follow-up visits, in which complex medical decision-
making is often required to manage patients’ gastrointestinal
illness. In addition to screening for osteoporosis, this health
maintenance includes appropriate vaccinations, screening
for depression and anxiety, and melanoma screening.
However, the low compliance rate could also be due to lack
of knowledge of osteoporosis screening recommendations
or due to deferring DEXA testing to primary care physicians.
Of note, the DEXA testing rate in the county clinic was
higher, possibly because of a higher proportion of female
patients compared to the veterans’ clinic.
4.1. Study Strengths and Limitations. Postintervention, os-
teoporosis screening rate improvement was impressive,
increasing overall by 56%. 'e main strength of this quality
improvement project is that the intervention was simple to
implement, yet very effective in increasing the rate of DEXA
scans from 29% to 85%. 'is potentially could lead to the
ability to identify more patients with osteoporosis and refer
them for appropriate treatment to prevent bone fractures. A
single educational session, using a PowerPoint presentation
and giving handout material, served to educate and remind
the fellows about existing guidelines and reinforce the im-
portance of osteoporosis screening. It was easy to incor-
porate a brief template into the clinic notes via the two
electronic medical record (EMR) systems at the two clinic
locations. 'is template prompted the GI fellows to review
charts and inquire from patients about risk factors for low
BMD and if appropriate, order a DEXA scan. Our data is in
line with other reports where similar interventions (con-
sisting of provider education, chart reminders, EMR-based
prompts, and patient education) had a positive impact on
BMD screening rates, which in one study resulted in rate
increase from 10.8 to 81.1% [16–18].
We are aware of some limitations of this study. First,
some patients may have received medical care and DEXA
scans at other hospitals in the community, and this would
not be captured in our chart review. However, we expect this
number to be very small as most veterans get all their care at
the VA hospital, and similarly, most patients of the county
clinic receive their care at the county hospital. Second, we
collected the data retrospectively which could lead to the
underestimation of patients who met the screening criteria
as the data regarding steroid use or previous fractures might
be missing. Finally, our study design did not allow us to
Table 1: Demographic data, characteristics, and DEXA screening rate for IBD patients who are at risk of osteoporosis.
Preintervention phase (12 weeks) Postintervention phase (12 weeks)
VA County All VA County All
Total clinic patients 368 375 743 402 403 805
No. of IBD patients 45 35 80 46 35 81
UC 21 15 36 23 13 36
Crohn’s 22 20 42 20 22 42
Indeterminate 2 0 2 3 0 3
Male, N (%) 42 (93.3%) 13 (37.1%) 55 (68.8%) 45 (97.8%) 13 (37.1%) 58 (71.6%)
Age (years), mean± SD 61.6± 15.0 46.8± 14.4 55.1± 16.5 62.7± 16.4 45.1± 12.7 55.1± 17.2
No. of IBD patients who met DEXA screening criteria, N (%) 29 (64.4%) 16 (45.7%) 45 (56.3%) 28 (60.9%) 19 (54.3%) 47 (58.0%)
Steroid criteria 13 14 27 11 18 29
Age criteria 19 3 22 19 1 20
Fracture criteria 0 1 1 0 2 2
Patients who received appropriate screening DEXA scan, N
(%) 6 (20.7%) 7 (43.8%) 13 (28.9%) 21 (75.0%) 19 (100.0%) 40 (85.1%)
IBD, inflammatory bowel disease; UC, ulcerative colitis; SD, standard deviation; DEXA scan, dual-energy X-ray absorptiometry
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determine the longevity of the positive effect of this inter-
vention, before we would need to reimplement the
intervention.
5. Conclusions
In conclusion, it was evident that many of the GI fellows’
IBD patients at risk for osteoporosis were not receiving
appropriate BMD screening. We were able to remarkably
improve the rate of obtaining screening DEXA scans from
29% to 85% through a simple intervention of educating GI
fellows and adding a template to the EMR clinic notes. Our
hope is that these positive results would lead to an early
diagnosis and treatment of osteoporosis, before ensuing
complications and morbidities. 'is quality initiative could
potentially be replicated successfully in other settings, such
as clinics of GI attendings or advanced practice providers,
both at our institution and at other institutions, and has a
larger-scale preventative impact to improve outcomes of
IBD patients.
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